Next Article in Journal
Antimicrobial Resistance and Clonal Lineages of Escherichia coli from Food-Producing Animals
Previous Article in Journal
The Research Status, Potential Hazards and Toxicological Mechanisms of Fluoroquinolone Antibiotics in the Environment
Previous Article in Special Issue
Occult Vancomycin-Resistant Enterococcus faecium ST117 Displaying a Highly Mutated vanB2 Operon
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes in mcr-Harbouring Colistin-Resistant Enterobacteriaceae Isolates Recovered from Poultry and Poultry Meats in Malaysia

1
Department of Veterinary Pathology & Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
2
Bangladesh Livestock Research Institute, Savar, Dhaka 1341, Bangladesh
3
Institute of Bioscience, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
4
Department of Veterinary Laboratory Diagnostics, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
5
Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(6), 1060; https://doi.org/10.3390/antibiotics12061060
Submission received: 17 April 2023 / Revised: 18 May 2023 / Accepted: 31 May 2023 / Published: 15 June 2023

Abstract

:
The co-existence of the colistin resistance (mcr) gene with multiple drug-resistance genes has raised concerns about the possibility of the development of pan-drug-resistant bacteria that will complicate treatment. This study aimed to investigate the antibiotic resistance profiles and co-existence of antibiotic resistance genes among the colistin-resistant Enterobacteriaceae isolates recovered from poultry and poultry meats. The antibiotic susceptibility to various classes of antibiotics was performed using the Kirby-Bauer disk diffusion method and selected antimicrobial resistance genes were detected using PCR in a total of 54 colistin-resistant Enterobacteriaceae isolates including Escherichia coli (E. coli) (n = 32), Salmonella spp. (n = 16) and Klebsiella pneumoniae (K. pneumoniae) (n = 6) isolates. Most of the isolates had multi-drug resistance (MDR), with antibiotic resistance against up to seven classes of antibiotics. All mcr-harbouring, colistin-resistant Enterobacteriaceae isolates showed this MDR (100%) phenotype. The mcr-1 harbouring E. coli isolates were co-harbouring multiple antibiotic resistance genes. The seven most commonly identified resistance genes (blaTEM, tetA, floR, aac-3-IV, aadA1, fosA, aac(6_)-lb) were detected in an mcr-1-harbouring E. coli isolate recovered from a cloacal swab. The mcr-5 harbouring Salmonella spp. isolate recovered from poultry meats was positive for blaTEM, tetA, floR, aac-3-IV, fosA and aac(6_)-lb genes. In conclusion, the colistin-resistant Enterobacteriaceae with mcr genes co-existing multiple clinically important antimicrobial resistance genes in poultry and poultry meats may cause potential future threats to infection treatment choices in humans and animals.

1. Introduction

Antibiotics are prescribed to treat infections caused by bacterial strains, including Enterobacteriaceae, but the prevalence of antibiotic resistance has reached epidemic proportions in humans and animals, acknowledged as a rising severe threat to public health and food safety globally. Human medications used as growth stimulants or animal preventive agents have been blamed for exacerbating the global dilemma of antibiotic resistance [1].
The spread of drug-resistant Enterobacteriaceae infections was also facilitated by improper antibiotic usage in humans and animals as well as greater accessibility worldwide [2]. Multidrug-resistant (MDR) (resistant to three or more different antimicrobial classes), organisms, including ESBL, are commonly known as “superbugs” that severely limit potential treatments and are linked to higher mortality, morbidity, and financial consequences [3]. Multidrug-resistant (MDR) Escherichia coli, Salmonella spp. and Klebsiella pneumoniae are significant members of Enterobacteriaceae that are capable of acquiring resistance to various types of antibiotics including aminoglycosides, carbapenems, fluoroquinolones and cephalosporins [4].
Colistin is a positively charged polypeptide antibiotic and is used significantly to treat Gram-negative bacterial infections [5]. Nevertheless, due to their neuro- and nephrotoxicity, as well as the availability of comparatively “safer” medications such as beta-lactams, they were no longer prescribed in the 1980s [6]. Colistin was reintroduced in the 1990s to combat the uncontrollable spread of XDR (extensively drug-resistant) and MDR bacteria, including carbapenem-resistant bacterial strains, despite their continued harmful effects [7]. Colistin was recognised as one of the Human Highest Priority Critically Important Antimicrobials (HPCIA) by the World Health Organization (WHO) since 2017 [8,9]. Because of the lack of new, potent, and safer antibiotics, colistin plays a pivotal role in modern healthcare as a last-line antibiotic for treating severe infections [10]. Like all other antibiotics, bacteria have developed resistance to colistin, as evidenced by several recent studies indicating the advent and global dissemination of colistin resistance [8,11,12].
The plasmid-mediated colistin resistance mcr gene was first reported in China in November 2015 in numerous bacterial strains, including E. coli, Salmonella spp. and Klebsiella pneumoniae, isolated from aquatic environments, humans and animals [11,12,13]. Until 2015, colistin resistance was thought to be caused by alterations of chromosomally mediated-genes, which disseminate vertically and slowly [14]. Nevertheless, the acquisition of various colistin resistance (mcr) genes, including mcr-1 to mcr-10 encoded on plasmids, has sped up the dissemination of colistin resistance.
Salmonella isolates in chicken carcasses in Peninsular Malaysia have shown sensitivity to cephalosporin, but 5% isolates have shown multidrug resistance in which the highest resistance was observed against streptomycin (66.6%), followed by tetracycline (44.3%) and trimethoprim-sulfamethoxazole (16.6%) [15]. The occurrence of ESBL- E. coli was 48.8 % in poultry meat in Malaysia [16]. Retail poultry meat has been identified in Malaysia as a common reservoir of multi-drug resistant Salmonella, accounting for 6.7% of S. enteritidis [17]. In another report, 27 (57.45%) of the Salmonella isolates from Malaysian chicken and chicken meat were found to be resistant to one or more antibiotics tested [18]. Genotypic determinants for resistance, such as floR, cmlA, tetA, tetB, tetG, temB, blaPSE-1, sul1, sul2, qnrA, qnrS, strA and aadA, have been identified among MDR Salmonella strains [19]. In Malaysia, colistin resistance with the mcr-1 gene was first noted in E. coli isolated from chicken [20,21]. The co-resistance to β-lactamases and colistin antibiotics were also observed in K. pneumoniae isolates in swine [22]. The co-existence of colistin resistance (mcr) gene with genes encoding resistance to multiple antibiotics, such as carbapenem, extended-spectrum β-lactam, tetracycline, sulfamethoxazole, ciprofloxacin and trimethoprim, raises concerns about the possibility of development of pan-drug-resistant bacteria [23,24]. Hence, the purpose of this research was to determine the antimicrobial resistance profile and co-existence of mcr genes with other multiple antibiotic resistance genes among the colistin-resistant Enterobacteriaceae isolates recovered from poultry and poultry meats.

2. Results

2.1. Colistin Resistance in the Isolates

In broth microdilution tests, all the 54 isolates were classified as colistin resistant with MIC values ranging from 4–128 µg/mL colistin. In molecular detection for colistin resistance, mcr gene was observed in seven isolates, including six E. coli isolates with mcr-1 gene and 1 Salmonella spp isolate with mcr-5 gene.

2.2. Phenotypic Detection of Antimicrobial Resistance

2.2.1. Rate of Antimicrobial Resistance to Enterobacteriaceae

Antimicrobial resistance (%) rates were grouped and labelled based on the following rate ranges: >70%, >50 to 70%, >20 to 50%, >10 to 20%, >1 to 10%, 0.1 to 1% and <0.1% as extremely high, very high, high, moderate, low, very low and rare, respectively, according to Papadopoulos et al. (2021) and Adebowale et al. (2022). According to this categorization scheme, it was found that the isolated colistin-resistant E. coli rates were: extremely high in resistance to tetracycline (93.8%); very high in resistance to streptomycin (59.4%) and nalidixic acid (56.3%); and high in rates of resistance to ciprofloxacin and gentamycin (46.9%), tobramycin (43.8%), chloramphenicol (40.6%), cefotaxime (34.4%), norfloxacin (31.3%), ceftriaxone (28.1%) and fosfomycin (25%).
In the case of Salmonella spp., very high rates of resistance were found against tetracycline (68.8%), high rates of resistance to chloramphenicol (37.5%), nalidixic acid (31.3%), streptomycin (25%) and ciprofloxacin (25%) and gentamycin (25%). In addition, a moderate resistance rate was observed for tobramycin (12.5%), and a low resistance rate was found for cefotaxime and ceftriaxone (6.3%).
As for Klebsiella pneumoniae isolates, extremely high resistance rates were noted for ciprofloxacin (83.3%), very high rates of resistance were observed for tetracycline (66.7%) and chloramphenicol (50%), high resistance rates were detected against streptomycin and nalidixic acid (33.3%). Figure 1 presents an overview of the antimicrobial resistance profiles among the 54 isolates.
Colistin-resistant E. coli isolates originating from litter samples showed 100% (2, 2/2) resistance to streptomycin, ciprofloxacin, tetracycline, norfloxacin, nalidixic acid and chloramphenicol. The isolates originated from litter samples showed the highest resistance to these antibiotics compared with isolates recovered from cloacal swabs and meat samples. On the other hand, there was a low rate of resistance to fosfomycin (1, 1/7, 14.3%) for the E. coli isolated from the cloacal swab. (Figure 2).
Colistin-resistant Salmonella spp. isolates obtained from cloacal swabs showed 100% (3, 3/3) resistance to tetracycline and nalidixic acid, and isolates recovered from litter samples showed 100% (2, 2/2) resistance to ciprofloxacin and tetracycline. In contrast, the highest rate from meat samples, 54.5% (n = 6, 6/11) of isolates, was found to be resistant to tetracycline (Figure 2).
Colistin-resistant K. pneumoniae isolates obtained from cloacal swabs and litter samples showed 100% resistance to tetracycline and chloramphenicol, respectively. Ciprofloxacin resistance was observed in 100% isolates originating from litter samples and meat samples (Figure 2).

2.2.2. Antimicrobial Resistance Profile

Multidrug resistance (MDR) was found in the majority of Enterobacteriaceae isolates (85.19%, 46/54). This total was further summarized by species groups. Among the colistin-resistant E. coli isolates, 94% (n = 30) of isolates were MDR, with five different patterns of resistance against three (3) to seven (7) classes of antibiotics. E. coli isolates had the largest number with resistance to seven classes of antibiotics, 16% (n = 5) (Figure 3). Among Salmonella spp. isolates, 68.5% (n = 11) were MDR, with four patterns. The highest proportion of these MDR isolates, 31% (n = 5), were found to be resistant to four classes of antibiotics, followed by 25% (n = 4) of isolates with resistance to three classes of antibiotics. On the other hand, 6% (n = 1) Salmonella spp. isolates had resistance to six classes of antibiotics, which was the highest number of antibiotic classes for this group (Figure 3). In K. pneumoniae, 83% (n = 5) of isolates were MDR, with only two patterns, and 67% (n = 4) of isolates were found to be resistant to four classes of antibiotics (Figure 3). All seven mcr-habouring colistin-resistant Enterobacteriaceae, including E. coli (n = 6) and Salmonella spp. (n = 1) were of the MDR phenotype (Table 1).

2.2.3. Multiple Antibiotic Resistance Index (MARI)

A total of 54 colistin-resistant isolates showed various antibiotic resistance patterns in the current study. Among these isolates, 85.19% (46/54) had MARI greater than 0.2, from which 38.89% (21/54) of isolates showed MARI of more than 0.4. Out of 32 E. coli, 93.75% (n = 30) and 62.5% (n = 20) of E. coli isolates showed MARI more than 0.2 and 0.4, respectively. The highest MARI value of 0.79 was observed in two E. coli isolates which were recovered from cloacal swabs and chicken meat samples (Table S4). MARI of 0.29 was found in 21.9% of isolates, followed by MARI of 0.43 in 18.8% of isolates, and the highest MARI of 0.79 was determined in 6% of isolates (Figure S1). In total, 68.75% (n = 11) and 6.25% (n = 1) of Salmonella spp. isolates had MARI values of more than 0.2 and 0.4, respectively (Table S5). MARI of 0.21 was observed in 25% of isolates, and the highest MARI of 0.71 was noted in 6.25% of isolates (Figure S2). However, 83.33% (n = 5) of K. pneumoniae isolates showed MARI of >0.2. None of the K. pneumoniae isolates had MARI higher than 0.4 (Table S6). The majority of the K. pneumoniae isolates had MARI of 0.29 and 0.36 (Figure S3).

2.3. Other Antibiotic Resistance Genes in Colistin-Resistant Enterobacteriaceae

Among colistin-resistant Enterobacteriaceae isolates, 51.9% (n = 28) were positive for the tetA gene, followed by blaTEM (35.2%, n = 19) and floR (35.2%, n = 19) genes. Whereas only 1.9% (n = 1) isolate showed positive for the catA1 gene (Figure 4). The presence of tetA, floR, aadA1, fosA, and aac(6_)-lb genes were observed in E. coli, Salmonella spp., and K. pneumoniae isolates. Two genes, blaTEM and aac-3-IV, were found both in E. coli and Salmonella spp. isolates. The blaSHV gene was detected only in K. pneumoniae isolates (66.67%), and the occurrence of catA1 genes was noted only in E. coli isolates. The resistance gene that was most common among all colistin-resistant Enterobacteriaceae was the tetA gene, detected in 53.13% of E. coli, 50% of Salmonella spp., and 50% of K. pneumoniae isolates (Figure 5).
The β-lactamase genes and other antimicrobial resistance genes were observed in colistin-resistant Enterobacteriaceae. Specifically, 33.33% had the blaSHV gene, 83.3% had the tetA gene, 83.3% had the floR gene and 66.7% had the aadA1 gene, and these were found to be significantly more common in Enterobacteriaceae isolated from litter samples than from other sources (Table 2, p < 0.05). Out of 54 colistin-resistant Enterobacteriaceae isolates, 29 isolates were positive for at least one resistance gene, in which 18 different patterns of resistance were observed (Table 3).
All colistin-resistant E. coli isolated from litter samples were found to harbour tetA and floR genes. This contrasted with isolates from cloacal swabs and meat samples, although no statistically significant difference was found (p > 0.05). The aadA1 gene was found in 100% of colistin-resistant E. coli isolated in litter samples. This frequency was significantly higher than that among E. coli obtained from cloacal swabs and meat samples (Table S7, p < 0.05). In contrast, the catA1 gene was confirmed in 4.3% of colistin-resistant E. coli isolated from meat samples. Out of 32 colistin-resistant E. coli isolates, 17 isolates were detected with at least one resistance gene, in which 11 different patterns of genotypic resistance were observed. Resistance to seven genes (blaTEM, tetA, floR, aac-3-IV, aadA1, fosA, aac(6_)-lb) was detected in one isolate (Table 3).
All colistin-resistant Salmonella spp. isolated from the cloacal swab harboured the tetA gene, and no other resistance genes were detected. The tetA gene was also detected from Salmonella spp. obtained from two other sources. The blaTEM, floR and fosA genes were detected from Salmonella spp. of litter and meat samples (Table S8). Out of 16 colistin-resistant Salmonella spp. isolates, eight isolates were positive for at least one resistance gene, in which four different patterns of resistance were observed. The highest number of resistance genes (blaTEM, tetA, floR, aac-3-IV, fosA, aac(6_)-lb), six, were detected in one isolate, followed by five genes in one isolate, four genes in three isolates and one gene in 3 isolates (Table 3).
Colistin-resistant K. pneumoniae isolates originated from three different sources were found to be positive for blaSHV and fosA genes, whereas tetA, floR, aadA1, and aac(6_)-lb genes were detected from the isolates obtained from cloacal swab and litter samples. No other genes were observed in K. pneumoniae isolates (Table S9). Out of 6 colistin-resistant K. pneumoniae isolates, four isolates were positive for at least two resistance genes, in which, three different patterns of resistance were observed. Six resistance genes (blaSHV, tetA, floR, aadA1, fosA, aac(6_)-lb) were detected in two isolates, followed by three genes in one isolate and two genes in one isolate (Table 3).
The mcr-habouring Enterobacteriaceae isolates also possessed multiple antibiotic resistance genes (Table 4).

3. Discussion

Antimicrobial resistance (AMR) is a significant worldwide public health hazard, according to the World Health Organization, and it is predicted that AMR-related mortality could reach 10 million deaths by 2050 and cost 100 trillion USD [25]. In the population, colistin resistance, mcr genes may continue to be maintained due to the co-existence of resistance genes for the other antimicrobials [26,27]. Resistance to multiple classes of antimicrobials were tested in this investigation of the frequency of multidrug resistance with colistin. This current study revealed the varying degree of resistance to different classes of antibiotics. It is widely acknowledged that the poultry sector is a significant environment for the global spread of AMR due to the indiscriminate use of antibiotics in poultry agriculture [25]. We noted high resistance rates to frequently prescribed antibiotics and significant prevalence of MDR against 3 to 11 antibiotics. We also observed various patterns of AMR in colistin-resistant Enterobacteriaceae isolates recovered from chicken meats, cloacal swabs, and litter samples. Colistin-resistant E. coli isolates were found to be highly resistant to tetracycline, followed by streptomycin, nalidixic acids, ciprofloxacin, gentamicin, tobramycin, chloramphenicol, and cefotaxime. A recent study in Bangladesh found that 100% of colistin-resistant E. coli isolates were resistant to tetracycline, followed by erythromycin (92%), nalidixic acid (77%), gentamycin (62%), ciprofloxacin (46%), chloramphenicol (15%) and cefotaxime (8%), and all mcr-1 bearing isolates were sensitive to imipenem and fosfomycin [28]. Similarly, all mcr-1-habouring E. coli isolates were sensitive to imipenem and meropenem, but three out of seven isolates were resistant to fosfomycin in our study. In contrast, mcr-1-bearing E. coli isolates recovered from poultry in Nepal were reported resistant to imipenem (32.9%) and meropenem (2.6%) [8]. Modifying the mechanism of carbapenemase production could have led to the development of bacterial strains’ resistance to extended-spectrum beta-lactamases (ESBLs). MDR was found in almost all colistin-resistant E. coli isolates, showing various patterns of MDR against three to seven classes of antibiotics. Sixteen percent of isolates were observed to be resistant to the highest number of antibiotic classes (seven classes, including 11 antibiotics). A study from Nepal showed that 80% of E. coli recovered from poultry were MDR [8]. The presence of colistin-resistant MDR E. coli is threatening in the areas where fatality due to infectious diseases is frequent.
All colistin-resistant Salmonella spp. isolates were sensitive to meropenem, imipenem and fosfomycin and highly resistant to tetracycline, followed by chloramphenicol and nalidixic acids, and very few were resistant to cefotaxime and ceftriaxone. According to a study on mcr-positive isolates, they remain sensitive to many other antibiotics [29]. In another study, mcr-1 positive Salmonella typhimurium strains showed that all (n = 3) were resistant to cefotaxime and cefepime and sensitive to meropenem, imipenem and fosfomycin [30]. Most of the colistin-resistant Salmonella spp. isolates demonstrated MDR, phenotypically, which is corroborated with a recent study, in which almost all (92.3%, 48/52) mcr-positive isolates were MDR [31].
The isolated colistin-resistant K. pneumoniae strains were phenotypically resistant to five classes of antibiotics, and high rates of resistance were observed to ciprofloxacin, tetracycline and chloramphenicol. Colistin-resistant Klebsiella pneumoniae isolates in Taiwan were resistant to 17 antimicrobials, and 67.3% of isolates were resistant to ciprofloxacin [32]. In contrast, most K. pneumoniae isolates in Pakistan were documented to be resistant to colistin (70%), but all showed resistance to tetracycline [33].
Among the studied colistin-resistant isolates, 18 various antibiotic resistance patterns were identified. Among these isolates, 85.19% (46/54) had a MAR index greater than 0.2, from which 38.89% (21/54) showed MAR index >0.4. Species-wise, 93.75% of E. coli, 68.57% of Salmonella spp., and 83.33% of K. pneumoniae isolates were found to have MARI values of >0.2. A MAR index of >0.2 denotes the overuse or abuse the antimicrobials in humans and animals, and a MAR index of >0.4 suggests contamination from feces as a source. On the other hand, a MAR index ≤0.2 indicates the infrequent or no use of antibiotics, and a MAR index ≤0.4 implies contamination with non-human feces [34]. Our findings are consistent with results in poultry carcasses in Egypt, in which 86.8% of isolates were reported with MAR index value >0.2 [35], and more than 94% of E. coli isolates were documented with MARI value of >0.2 in South Africa [36]. It might be dangerous to both public health and the poultry sector.
Escherichia coli is a significant source of the resistance genes that have been linked to both human and animal therapeutic failure [37]. Most of the colistin-resistant E. coli isolates harboured the tetA gene followed by blaTEM, floR, aadA1, aac-3-IV, aac(6_)-lb. A few isolates were positive for catA1 and fosA genes. None of the E. coli isolates possessed the blaSHV gene. Two out of 13 colistin-resistant E. coli isolates in Bangladesh were documented to have both the mcr-1 and blaTEM genes [28]. The co-existence of the plasmid-borne ESBL and mcr-1 genes may help spread of resistance to colistin [38]. It may help superbugs develop and spread, making them resistant to all antibiotics currently available on the market. Furthermore, we observed multiple AMR genes in 15 of the 32 colistin-resistant E. coli isolates, which may indicate the co-transfer of various AMR genes. Beta-lactamase and fluoroquinolone resistance genes were found together and were prominent in our isolates. Beta-lactams and fluoroquinolones are both significant and frequently prescribed antimicrobials in clinical settings. Public health could be harmed by the co-transfer of these two categories of genes [39]. While mcr-4-habouring isolates were reported to co-exist with the catA1 gene, which encodes chloramphenicol resistance, in Spain and Belgium [40], in our study, the catA1 gene was found in only one mcr-1-habouring colistin-resistant E. coli isolate. According to our research, E. coli from chicken meat may be a source of resistance genes that could spread to other common bacteria. Despite not exhibiting the phenotype, few isolates carried resistance genes, which may have been caused by the genes being silenced or under transcriptional regulatory control [39]. To better understand the mechanism, more research is necessary.
Colistin-resistant Salmonella spp. isolates were found to be positive for tetA, TEM, floR, aac-3-IV, and aac(6_)-lb genes, which were in accordance with their resistance phenotypes. Moreover, though the one resistant Salmonella spp. was found with the fosA gene, it was sensitive to fosfomycin phenotypically. Similarly, a previous study showed that Salmonella spp. was carrying a quinolone resistance gene, but was sensitive to levofloxacin and ciprofloxacin, which might be due to the non-expression of this gene [30].
The present study showed the existence of SHV, tetA, floR, aadA1, aac(6_)-lb, and fosA genes in colistin-resistant Klebsiella pneumoniae isolates, with SHV gene predominance. Colistin-resistant Klebsiella pneumoniae isolates recovered from humans in India were also reported genotypically resistant to various antibiotics, including TEM, SHV, aadA2, aac(6′)-lb-cr, tetD, fosA [41].
Various antibiotic resistance genes in bacteria found in poultry and poultry meat are regarded as a significant risk to human health. Combining any of the two antibiotic resistant genes can make it possible for microbes to acquire many genes at once and quickly form high-risk pathogenic organisms. A previous study in Canada has documented the potential risk of dissemination of drug resistant bacteria to humans via the consumption of poultry [42]. A study in Ghana suggested that chicken bacterial isolates and human bacterial isolates had a high degree of similarity, signalling that resistant bacteria could be spreading between humans and animals [43]. To stop the spread of such resistant microorganisms via contaminated foods, rigorous hygiene precautions are therefore required [44]. It is important to educate the public about such novel risks and to instruct those working in the veterinary and animal agriculture sectors on how to use antibiotics responsibly.

4. Materials and Methods

4.1. Bacterial Strains and Study Design

A total of 54 colistin-resistant Enterobacteriaceae, including E. coli (n = 32), Salmonella spp. (n = 16) and Klebsiella pneumoniae (n = 6) were used in this study, which were recovered from chicken meat, cloacal swabs (CS) and litter samples from supermarkets and poultry farms, in Selangor, Malaysia, from 2019 to 2021. These bacteria were isolated and identified using traditional culture and biochemical tests [45,46,47], and confirmed with PCR using species-specific gene primers [48,49,50]. Colistin resistance was confirmed with broth microdilution (BMD) assay as recommended by EUCAST, and colistin minimum inhibitory concentrations (MIC) were recorded. According to EUCAST, Enterobacteriaceae having an MIC > 2 µg/mL against colistin were defined as colistin resistant. The genomic DNA of the colistin-resistant isolates was assessed with conventional PCR to detect colistin resistance (mcr) gene variants (mcr-1 to mcr-10), in which E. coli ATCC25922 and E. coli NCTC 13846 were used as negative control and positive control, respectively. All the colistin-resistant isolates (Table 5) were subjected to antimicrobial susceptibility tests for various classes of antibiotics for the phenotypic profile and to determine the genotypic determinants of antibiotic resistance.

4.2. Phenotypic Antimicrobial Resistance Testing

The colistin-resistant E. coli, Salmonella spp., and K. pneumoniae isolates were phenotypically tested for their susceptibility to various classes of antibiotics, including aminoglycosides (S, Streptomycin; CN, Gentamycin; TOB, Tobramycin), fluoroquinolones (CIP, Ciprofloxacin; NOR, Norfloxacin; NA, Nalidixic acid), tetracyclines (TE, Tetracycline), cephalosporin (CTX, Cefotaxime; CRO, Ceftriaxone), fosfomycins (FOS, Fosfomycin) and chloramphenicol (C) by the Kirby–Bauer disk diffusion standard method [51,52]. A fresh culture of each isolate, with a concentration of 0.5 McFarland standard, was plated on Mueller–Hinton agar (Oxoid, UK) plates and incubated at 37 °C for 18–24 h. The results of the test were measured with digital slide callipers and recorded according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [51].

4.2.1. Rates of Antimicrobial Resistance (AMR)

The following calculation was used to determine the percentage of resistant isolates for each antibiotic.
%   rate = Number   of   resistant   isolates   ×   100 Number   of   tested   isolates
According to Papadopoulos et al. (2021) and Adebowale et al. (2022), rates (%) of resistance were classified into % rate >70%, >50 to 70%, >20 to 50%, >10 to 20%, >1 to 10%, 0.1 to 1% and <0.1% as extremely high, very high, high, moderate, low, very low and rare, respectively [25,53].

4.2.2. Multidrug Resistance (MDR) Patterns

Drug resistance was categorized based on Sweeney et al. [54]. Briefly, the MDR isolates were defined as the isolates that were non-susceptible to at least three antibiotics classes [54].

4.2.3. The Multiple Antibiotic Resistance Index (MARI)

The formula: a/b, was used to calculate and interpret the multiple antibiotic resistance index (MARI), where “a” represents how many antibiotics an isolate proved resistance to, and “b” represents how many antibiotics were tested in total [36,55,56,57]. MARI values were compared to the threshold value of 0.2. A MARI value >0.2 implies that the original sources of isolates likely involved heavy antibiotic use or misuse of antibiotics [35], whereas <0.2 denotes samples from sources with less antibiotic usage or low risk [55]

4.3. Detection of Antimicrobial Resistance Genes

4.3.1. DNA Extraction

The extraction of genomic DNA of all colistin-resistant isolates, including E. coli, Salmonella spp. and K. pneumoniae isolates, was performed by using the commercially available DNeasy® Blood & Tissue Kit (QIAGEN GmbH, Hilden, Germany).

4.3.2. Polymerase Chain Reaction

The genomic DNA of colistin-resistant isolates was subjected to PCR for the detection of antimicrobial-resistant genes against specific antibiotics, including β-lactamase genes (blaCTX-M, blaTEM, and blaSHV), Aminoglycosides (Gentamycin, aac-3-IV, Streptomycin, aadA1), Fluoroquinolones (Ciprofloxacin, aac(6-)-lb), Tetracyclines (Tetracycline, tetA), Chloramphenicol (catA1 and floR) and Fosfomycins (Fosfomycin, fosA) by previously designed oligonucleotide primers and protocols (Tables S1 and S2) [36,58,59,60,61,62,63,64].
The PCR assay was carried out in 25 µL reaction mixture containing 2× master mix (MyTaqTM Red Mix, Bioline, UK), each with forward and reverse primers (10 pmol/µL), PCR-grade water, and DNA template (Table S3) using an Eppendorf Mastercycler pro S (Hamburg, Germany).

4.3.3. Agarose Gel electrophoresis

The PCR products were electrophoresed at 80 V for 60 min in a gel electrophoresis system (Enduro, Labnet, Taiwan) through 1.5% (w/v) agarose gel (GeneDireX, New Jersey, NJ, USA) prepared in 0.5× TBE buffer containing 0.04 µL/mL nucleic acid staining (ETB “out” Nucleic Acid, Cat. No. FYD007-200P, Yestern Biotech Co. ltd, Taiwan). Aliquots of 5 µL of PCR products were applied to the gel. Depending on the sizes of amplicons, a 100 bp DNA ladder RTU (Cat. No. DM001-R500, GeneDireX) was used as a size marker in each gel. Using the Alpha Innotech gel documentation system (AlphaImager 2200, Haverhill, MA, USA), expected bands for the relevant genes (Table S2) were seen and captured in photos under UV light. The obtained results of β-lactamase genes were verified by uniplex PCR analysis with the relevant gene.

4.4. Statistical Analysis

The differences in antibiotic resistance rates in colistin-resistant isolates (Salmonella spp., E. coli and K. pneumoniae strains) among sources (raw chicken meat, cloacal swab, litter) were tested using the chi-square (χ2) test in SPSS software v. 25.0 (IBM, Armonk, NY, USA). Statistical significance was considered at a p-value < 0.05.

5. Conclusions

Various numbers of antibiotic resistance genes were observed in the colistin-resistant Enterobacteriaceae isolates (E. coli, Salmonella spp., K. pneumoniae) tested in this current study. Most of the isolates were found to have multidrug resistance (MDR), with resistance to up to seven classes of antibiotics. The mcr gene of Enterobacteriaceae isolates was found to co-exist with multiple antibiotic resistance genes. Specifically, blaTEM, tetA, floR, catA1, aac-3-IV, aadA1, fosA, aac(6_)-lb genes co-existed with mcr-1 in E. coli and blaTEM, tetA, floR, aac-3-IV, fosA, aac(6_)-lb genes co-existed with mcr-5 in Salmonella spp. Colistin-resistant K. pneumoniae isolates were also detected with various numbers of resistance genes. The co-existence of several clinically important antimicrobial resistance genes in the present study exacerbates the antibiotic resistance problem in Malaysia and highlights significant concerns about potential future threats to infection treatment choices in humans and animals. This research will help to prepare the AMR surveillance and monitoring guidelines for policymakers throughout the country to mitigate the risk of AMR in humans and animals.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics12061060/s1, Table S1: List of the primers for AMR gene detection from Enterobacteriaceae; Table S2: PCR thermal profile for AMR gene detection; Table S3:PCR master mixtures in microcentrifuge tube for each isolate; Table S4: Antimicrobial resistance pattern and MARI of E. coli isolates; Table S5: Antimicrobial resistance pattern and MARI of Salmonella spp. Isolates; Table S6: Antimicrobial resistance pattern and MARI of K. pneumoniae isolates; Table S7: Prevalence of AMR genes in E. coli isolated from different sources; Table S8: Prevalence of AMR genes in Salmonella spp. isolated from different sources; Table S9: Prevalence of AMR genes in K. pneumoniae isolated from different sources; Figure S1: MARIs and percentages among of colistin-resistant E. coli and the percentage of isolates; Figure S2: MARIs and percentages among of colistin-resistant Salmonella spp. and their percentage of isolates; Figure S3: MARIs and percentages among of colistin-resistant K. pneumoniae and their percentage of isolates.

Author Contributions

Conceptualization, M.R.K. and Z.Z.; Methodology, M.R.K., Z.Z., L.H., N.M.F. and N.I.A.; Software, M.R.K. and Z.Z.; Validation, M.R.K., Z.Z., L.H., N.M.F. and N.I.A.; Formal Analysis, M.R.K.; Investigation, M.R.K. and Z.Z.; Resources, Z.Z.; Data Curation, M.R.K. and Z.Z.; Writing—Original Draft Preparation: M.R.K. and Z.Z.; Writing—Review & Editing: M.R.K., Z.Z., L.H., N.M.F. and N.I.A.; Visualization, M.R.K. and Z.Z.; Supervision, Z.Z.; Project Administration, Z.Z.; Funding Acquisition, M.R.K. and Z.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the UPM trust fund (grant number: 6282525) in collaboration with Bangladesh Agricultural Research Council (BARC), Dhaka, Bangladesh.

Institutional Review Board Statement

The ethical board of Universiti Putra Malaysia (UPM), Institutional Animal Care and Use Committee (IACUC), approved the research study protocol for collecting cloacal swabs from live poultry (UPM/IACUC/AUP-R091/2019).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors would like to thank the authorities of Bangladesh Agriculture Research Council, Bangladesh, and Universiti Putra Malaysia for their financial support during this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Founou, L.L.; Founou, R.C.; Essack, S.Y. Antibiotic Resistance in the Food Chain: A Developing Country-Perspective. Front. Microbiol. 2016, 7, 1881. [Google Scholar] [CrossRef]
  2. Tilahun, M.; Kassa, Y.; Gedefie, A.; Belete, M.A. Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review. Infect. Drug Resist. 2021, 14, 4363–4374. [Google Scholar] [CrossRef] [PubMed]
  3. Kayastha, K.; Dhungel, B.; Karki, S.; Adhikari, B.; Banjara, M.R.; Rijal, K.R.; Ghimire, P. Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella Species in Pediatric Patients Visiting International Friendship Children’s Hospital, Kathmandu, Nepal. Infect. Dis. Res. Treat. 2020, 13, 1178633720909798. [Google Scholar] [CrossRef] [Green Version]
  4. Sharahi, J.Y.; Hashemi, A.; Ardebili, A.; Davoudabadi, S. Molecular characteristics of antibiotic-resistant Escherichia coli and Klebsiella pneumoniae strains isolated from hospitalized patients in Tehran, Iran. Ann. Clin. Microbiol. Antimicrob. 2021, 20, 32. [Google Scholar] [CrossRef] [PubMed]
  5. Moubareck, C.A. Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance. Membranes 2020, 10, 181. [Google Scholar] [CrossRef] [PubMed]
  6. Yu, Z.; Qin, W.; Lin, J.; Fang, S.; Qiu, J. Antibacterial mechanisms of polymyxin and bacterial resistance. BioMed Res. Int. 2015, 2015, 679109. [Google Scholar] [CrossRef]
  7. Dandachi, I.; Sokhn, E.S.; Dahdouh, E.A.; Azar, E.; El-Bazzal, B.; Rolain, J.-M.; Daoud, Z. Prevalence and Characterization of Multi-Drug-Resistant Gram-Negative Bacilli Isolated From Lebanese Poultry: A Nationwide Study. Front. Microbiol. 2018, 9, 550. [Google Scholar] [CrossRef] [Green Version]
  8. Muktan, B.; Thapa Shrestha, U.; Dhungel, B.; Mishra, B.C.; Shrestha, N.; Adhikari, N.; Banjara, M.R.; Adhikari, B.; Rijal, K.R.; Ghimire, P. Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: First report from Nepal. Gut Pathog. 2020, 12, 44. [Google Scholar] [CrossRef]
  9. Poirel, L.; Jayol, A.; Nordmann, P. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. Clin. Microbiol. Rev. 2017, 30, 557–596. [Google Scholar] [CrossRef] [Green Version]
  10. Lenhard, J.R.; Bulman, Z.P.; Tsuji, B.T.; Kaye, K.S. Shifting Gears: The Future of Polymyxin Antibiotics. Antibiotics 2019, 8, 42. [Google Scholar] [CrossRef] [Green Version]
  11. Liu, Y.-Y.; Wang, Y.; Walsh, T.R.; Yi, L.-X.; Zhang, R.; Spencer, J.; Doi, Y.; Tian, G.; Dong, B.; Huang, X.; et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis. 2016, 16, 161–168. [Google Scholar] [CrossRef] [PubMed]
  12. Carroll, L.M.; Gaballa, A.; Guldimann, C.; Sullivan, G.; Henderson, L.O.; Wiedmann, M. Identification of Novel Mobilized Colistin Resistance Gene mcr-9 in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype Typhimurium Isolate. MBio 2019, 10, e00853-19. [Google Scholar] [CrossRef] [Green Version]
  13. Zhang, H.; Hou, M.; Xu, Y.; Srinivas, S.; Huang, M.; Liu, L.; Feng, Y. Action and mechanism of the colistin resistance enzyme MCR-4. Commun. Biol. 2019, 2, 36. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Olaitan, A.O.; Morand, S.; Rolain, J.-M. Mechanisms of polymyxin resistance: Acquired and intrinsic resistance in bacteria. Front. Microbiol. 2014, 5, 643. [Google Scholar] [CrossRef] [Green Version]
  15. Abatcha, M.G.; Effarizah, M.E.; Rusul, G. Prevalence, antimicrobial resistance, resistance genes and class 1 integrons of Salmonella serovars in leafy vegetables, chicken carcasses and related processing environments in Malaysian fresh food markets. Food Control 2018, 91, 170–180. [Google Scholar] [CrossRef]
  16. Aliyu, A.B.; Saleha, A.A.; Jalila, A.; Zunita, Z. Risk factors and spatial distribution of extended spectrum β-lactamase-producing- Escherichia coli at retail poultry meat markets in Malaysia: A cross-sectional study. BMC Public Health 2016, 16, 699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Thung, T.Y.; Mahyudin, N.A.; Basri, D.F.; Radzi, C.W.J.W.M.; Nakaguchi, Y.; Nishibuchi, M.; Radu, S. Prevalence and antibiotic resistance of Salmonella Enteritidis and Salmonella Typhimurium in raw chicken meat at retail markets in Malaysia. Poult. Sci. 2016, 95, 1888–1893. [Google Scholar] [CrossRef] [PubMed]
  18. Zakaria, Z.; Hassan, L.; Sharif, Z.; Ahmad, N.; Ali, R.M.; Husin, S.A.; Hazis, N.H.b.A.; Sohaimi, N.F.M.; Bakar, S.A.; Garba, B. Analysis of Salmonella enterica serovar Enteritidis isolates from chickens and chicken meat products in Malaysia using PFGE, and MLST. BMC Vet. Res. 2020, 16, 393. [Google Scholar] [CrossRef]
  19. Chuah, L.O.; Shamila Syuhada, A.K.; Mohamad Suhaimi, I.; Farah Hanim, T.; Rusul, G. Genetic relatedness, antimicrobial resistance and biofilm formation of Salmonella isolated from naturally contaminated poultry and their processing environment in northern Malaysia. Food Res. Int. 2018, 105, 743–751. [Google Scholar] [CrossRef]
  20. Yu, C.Y.; Ang, G.Y.; Chin, P.S.; Ngeow, Y.F.; Yin, W.-F.; Chan, K.-G. Emergence of mcr-1-mediated colistin resistance in Escherichia coli in Malaysia. Int. J. Antimicrob. Agents 2016, 47, 504–505. [Google Scholar] [CrossRef]
  21. Aklilu, E.; Raman, K. MCR-1 Gene Encoded Colistin-Resistant Escherichia coli in Raw Chicken Meat and Bean Sprouts in Malaysia. Int. J. Microbiol. 2020, 2020, 8853582. [Google Scholar] [CrossRef]
  22. Mobasseri, G.; Teh, C.S.J.; Ooi, P.T.; Thong, K.L. The emergence of colistin-resistant Klebsiella pneumoniae strains from swine in Malaysia. J. Glob. Antimicrob. Resist. 2019, 17, 227–232. [Google Scholar] [CrossRef] [PubMed]
  23. Joshi, P.R.; Thummeepak, R.; Paudel, S.; Acharya, M.; Pradhan, S.; Banjara, M.R.; Leungtongkam, U.; Sitthisak, S. Molecular Characterization of Colistin-Resistant Escherichia coli Isolated from Chickens: First Report from Nepal. Microb. Drug Resist. 2019, 25, 846–854. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, Y.; Zhang, R.; Li, J.; Wu, Z.; Yin, W.; Schwarz, S.; Tyrrell, J.M.; Zheng, Y.; Wang, S.; Shen, Z.; et al. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nat. Microbiol. 2017, 2, 16260. [Google Scholar] [CrossRef] [PubMed]
  25. Adebowale, O.; Makanjuola, M.; Bankole, N.; Olasoju, M.; Alamu, A.; Kperegbeyi, E.; Oladejo, O.; Fasanmi, O.; Adeyemo, O.; Fasina, F.O. Multi-Drug Resistant Escherichia coli, Biosecurity and Anti-Microbial Use in Live Bird Markets, Abeokuta, Nigeria. Antibiotics 2022, 11, 253. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, Y.; Xu, C.; Zhang, R.; Chen, Y.; Shen, Y.; Hu, F.; Liu, D.; Lu, J.; Guo, Y.; Xia, X.; et al. Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: An epidemiological comparative study. Lancet Infect. Dis. 2020, 20, 1161–1171. [Google Scholar] [CrossRef] [PubMed]
  27. Mead, A.; Billon-Lotz, C.; Olsen, R.; Swift, B.; Richez, P.; Stabler, R.; Pelligand, L. Epidemiological Prevalence of Phenotypical Resistances and Mobilised Colistin Resistance in Avian Commensal and Pathogenic E. coli from Denmark, France, The Netherlands, and the UK. Antibiotics 2022, 11, 631. [Google Scholar] [CrossRef]
  28. Johura, F.T.; Tasnim, J.; Barman, I.; Biswas, S.R.; Jubyda, F.T.; Sultana, M.; George, C.M.; Camilli, A.; Seed, K.D.; Ahmed, N.; et al. Colistin-resistant Escherichia coli carrying mcr-1 in food, water, hand rinse, and healthy human gut in Bangladesh. Gut Pathog. 2020, 12, 5. [Google Scholar] [CrossRef] [Green Version]
  29. Quan, J.; Li, X.; Chen, Y.; Jiang, Y.; Zhou, Z.; Zhang, H.; Sun, L.; Ruan, Z.; Feng, Y.; Akova, M.; et al. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: A multicentre longitudinal study. Lancet Infect. Dis. 2017, 17, 400–410. [Google Scholar] [CrossRef]
  30. Zhao, D.; Yu, Y.; Quan, J.; Zhu, J.; Lu, J.; Wang, Y. Prevalence and molecular characteristics of mcr-1 gene in Salmonella typhimurium in a tertiary hospital of Zhejiang Province. Infect. Drug Resist. 2018, 12, 105–110. [Google Scholar] [CrossRef] [Green Version]
  31. Sia, C.M.; Greig, D.R.; Day, M.; Hartman, H.; Painset, A.; Doumith, M.; Meunier, D.; Jenkins, C.; Chattaway, M.A.; Hopkins, K.L.; et al. The characterization of mobile colistin resistance (mcr) genes among 33,000 Salmonella enterica genomes from routine public health surveillance in England. Microb. Genom. 2020, 6, e000331. [Google Scholar] [CrossRef] [PubMed]
  32. Yang, T.-Y.; Wang, S.-F.; Lin, J.-E.; Griffith, B.T.S.; Lian, S.-H.; Hong, Z.-D.; Lin, L.; Lu, P.-L.; Tseng, S.-P. Contributions of insertion sequences conferring colistin resistance in Klebsiella pneumoniae. Int. J. Antimicrob. Agents 2020, 55, 105894. [Google Scholar] [CrossRef] [PubMed]
  33. Lomonaco, S.; Crawford, M.A.; Lascols, C.; Timme, R.E.; Anderson, K.; Hodge, D.R.; Fisher, D.J.; Pillai, S.P.; Morse, S.A.; Khan, E.; et al. Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates. PLoS ONE 2018, 13, e0198526. [Google Scholar] [CrossRef] [Green Version]
  34. Gessew, G.T.; Desta, A.F.; Adamu, E. High burden of multidrug resistant bacteria detected in Little Akaki River. Comp. Immunol. Microbiol. Infect. Dis. 2022, 80, 101723. [Google Scholar] [CrossRef]
  35. Elshebrawy, H.A.; Abdel-Naeem, H.H.S.; Mahros, M.A.; Elsayed, H.; Imre, K.; Herman, V.; Morar, A.; Sallam, K.I. Multidrug-resistant Salmonella enterica serovars isolated from frozen chicken carcasses. LWT 2022, 164, 113647. [Google Scholar] [CrossRef]
  36. Adegoke, A.A.; Madu, C.E.; Aiyegoro, O.A.; Stenström, T.A.; Okoh, A.I. Antibiogram and beta-lactamase genes among cefotaxime resistant E. coli from wastewater treatment plant. Antimicrob. Resist. Infect. Control 2020, 9, 46. [Google Scholar] [CrossRef] [PubMed]
  37. Poirel, L.; Madec, J.-Y.; Lupo, A.; Schink, A.-K.; Kieffer, N.; Nordmann, P.; Schwarz, S. Antimicrobial Resistance in Escherichia coli. Microbiol. Spectr. 2018, 6. [Google Scholar] [CrossRef] [Green Version]
  38. Dandachi, I.; Chabou, S.; Daoud, Z.; Rolain, J.M. Prevalence and emergence of extended-spectrum cephalosporin-, carbapenem- and colistin-resistant gram negative bacteria of animal origin in the Mediterranean basin. Front. Microbiol. 2018, 9, 2299. [Google Scholar] [CrossRef] [Green Version]
  39. Zhong, Y.; Guo, S.; Seow, K.L.G.; Ming, G.O.H.; Schlundt, J. Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates from Jurong Lake, Singapore with Whole-Genome-Sequencing. Int. J. Environ. Res. Public Health 2021, 18, 937. [Google Scholar] [CrossRef]
  40. Carattoli, A.; Villa, L.; Feudi, C.; Curcio, L.; Orsini, S.; Luppi, A.; Pezzotti, G.; Magistrali, C.F. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Eurosurveillance 2017, 22, 30589. [Google Scholar] [CrossRef] [Green Version]
  41. Pragasam, A.K.; Shankar, C.; Veeraraghavan, B.; Biswas, I.; Nabarro, L.E.B.; Inbanathan, F.Y.; George, B.; Verghese, S. Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India—A First Report. Front. Microbiol. 2017, 7, 2135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Manges, A.R.; Smith, S.P.; Lau, B.J.; Nuval, C.J.; Eisenberg, J.N.S.; Dietrich, P.S.; Riley, L.W. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: A case-control study. Foodborne Pathog. Dis. 2007, 4, 419–431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Falgenhauer, L.; Imirzalioglu, C.; Oppong, K.; Akenten, C.W.; Hogan, B.; Krumkamp, R.; Poppert, S.; Levermann, V.; Schwengers, O.; Sarpong, N.; et al. Detection and characterization of ESBL-producing Escherichia coli from humans and poultry in Ghana. Front. Microbiol. 2019, 10, 3358. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Sabala, R.F.; Usui, M.; Tamura, Y.; Abd-Elghany, S.M.; Sallam, K.I.; Elgazzar, M.M. Prevalence of colistin-resistant Escherichia coli harbouring mcr-1 in raw beef and ready-to-eat beef products in Egypt. Food Control 2021, 119, 107436. [Google Scholar] [CrossRef]
  45. Prasertsee, T.; Chokesajjawatee, N.; Santiyanont, P.; Chuammitri, P.; Deeudom, M.; Tadee, P.; Patchanee, P. Quantification and rep-PCR characterization of Salmonella spp. in retail meats and hospital patients in Northern Thailand. Zoonoses Public Health 2019, 66, 301–309. [Google Scholar] [CrossRef]
  46. Ghafur, A.; Shankar, C.; GnanaSoundari, P.; Venkatesan, M.; Mani, D.; Thirunarayanan, M.A.; Veeraraghavan, B. Detection of chromosomal and plasmid-mediated mechanisms of colistin resistance in Escherichia coli and Klebsiella pneumoniae from Indian food samples. J. Glob. Antimicrob. Resist. 2019, 16, 48–52. [Google Scholar] [CrossRef]
  47. Sharma, J.; Kumar, D.; Hussain, S.; Pathak, A.; Shukla, M.; Kumar, V.P.; Anisha, P.N.N.; Rautela, R.; Upadhyay, A.K.K.; Singh, S.P.P.; et al. Prevalence, antimicrobial resistance and virulence genes characterization of nontyphoidal Salmonella isolated from retail chicken meat shops in Northern India. Food Control 2019, 102, 104–111. [Google Scholar] [CrossRef]
  48. Moawad, A.A.; Hotzel, H.; Neubauer, H.; Ehricht, R.; Monecke, S.; Tomaso, H.; Hafez, H.M.; Roesler, U.; El-Adawy, H. Antimicrobial resistance in Enterobacteriaceae from healthy broilers in Egypt: Emergence of colistin-resistant and extended-spectrum β-lactamase-producing Escherichia coli. Gut Pathog. 2018, 10, 39. [Google Scholar] [CrossRef] [Green Version]
  49. Rahn, K.; De Grandis, S.A.A.; Clarke, R.C.C.; McEwen, S.A.A.; Galán, J.E.E.; Ginocchio, C.; Curtiss, R.; Gyles, C.L.L. Amplification of an invA gene sequence of Salmonella typhimurium by polymerase chain reaction as a specific method of detection of Salmonella. Mol. Cell. Probes 1992, 6, 271–279. [Google Scholar] [CrossRef]
  50. Ranjbar, R.; Izadi, M.; Hafshejani, T.T.; Khamesipour, F. Molecular detection and antimicrobial resistance of Klebsiella pneumoniae from house flies (Musca domestica) in kitchens, farms, hospitals and slaughterhouses. J. Infect. Public Health 2016, 9, 499–505. [Google Scholar] [CrossRef] [Green Version]
  51. CLSI. M100S: Performance Standards for Antimicrobial Susceptibility Testing an Informational Supplement for Global Application Developed through the Clinical and Laboratory Standards Institute Consensus Process, 26th ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2016. [Google Scholar]
  52. Hudzicki, J. Kirby-Bauer disk diffusion susceptibility test protocol. Am. Soc. Microbiol. 2009, 66, 208. [Google Scholar]
  53. Papadopoulos, D.; Papadopoulos, T.; Papageorgiou, K.; Sergelidis, D.; Adamopoulou, M.; Kritas, S.K.; Petridou, E.; Papadopoulos, D. Antimicrobial resistance rates in commensal Escherichia coli isolates from healthy pigs in Greek swine farms. J. Hell. Vet. Med. Soc. 2021, 72, 2909–2916. [Google Scholar] [CrossRef]
  54. Sweeney, M.T.; Lubbers, B.V.; Schwarz, S.; Watts, J.L. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens. J. Antimicrob. Chemother. 2018, 73, 1460–1463. [Google Scholar] [CrossRef]
  55. Krumperman, P.H. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl. Environ. Microbiol. 1983, 46, 165–170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Adzitey, F.; Rusul, G.; Huda, N. Prevalence and antibiotic resistance of Salmonella serovars in ducks, duck rearing and processing environments in Penang, Malaysia. Food Res. Int. 2012, 45, 947–952. [Google Scholar] [CrossRef]
  57. Titilawo, Y.; Sibanda, T.; Obi, L.; Okoh, A. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of faecal contamination of water. Environ. Sci. Pollut. Res. 2015, 22, 10969–10980. [Google Scholar] [CrossRef] [PubMed]
  58. Nzima, B.; Adegoke, A.A.; Ofon, U.A.; Al-Dahmoshi, H.O.M.; Saki, M.; Ndubuisi-Nnaji, U.U.; Inyang, C.U. Resistotyping and extended-spectrum beta-lactamase genes among Escherichia coli from wastewater treatment plants and recipient surface water for reuse in South Africa. New Microbes New Infect. 2020, 38, 100803. [Google Scholar] [CrossRef]
  59. Rahman, M.M.; Husna, A.; Elshabrawy, H.A.; Alam, J.; Runa, N.Y.; Badruzzaman, A.T.M.; Banu, N.A.; Al Mamun, M.; Paul, B.; Das, S.; et al. Isolation and molecular characterization of multidrug-resistant Escherichia coli from chicken meat. Sci. Rep. 2020, 10, 21999. [Google Scholar] [CrossRef]
  60. Shivakumaraswamy, S.K.; Vittal, V.K.D.R.; Sannejal, A.D.; Mundanda, D.M.; Chakraborty, J.R.M.R.A.; Karunasagar, I. Phenotypic & genotypic study of antimicrobial profile of bacteria isolates from environmental samples. Indian J. Med. Res. 2019, 149, 232–239. [Google Scholar]
  61. Ma, M.; Wang, H.; Yu, Y.; Zhang, D.; Liu, S. Detection of Antimicrobial Resistance Genes of Pathogenic Salmonella from Swine with DNA Microarray. J. Vet. Diagn. Investig. 2007, 19, 161–167. [Google Scholar] [CrossRef] [Green Version]
  62. Liao, C.H.; Hsueh, P.R.; Jacoby, G.A.; Hooper, D.C. Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia. J. Antimicrob. Chemother. 2013, 68, 2907–2914. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Park, C.H.; Robicsek, A.; Jacoby, G.A.; Sahm, D.; Hooper, D.C. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 2006, 50, 3953–3955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Guerrero-Ceballos, D.L.; Burbano-Rosero, E.M.; Mondragon, E.I. Characterization of antibiotic-resistant Escherichia coli associated with urinary tract infections in Southern Colombia. Univ. Sci. 2020, 25, 463–488. [Google Scholar] [CrossRef]
Figure 1. Species-wise representation of antibiotics resistance pattern of the Enterobacteriaceae isolates. CTX = Cefotaxime, S = Streptomycin, CIP = Ciprofloxacin, TOB = Tobramycin, CN = Gentamycin, CRO = Ceftriaxone, FOS = Fosfomycin, MEM = Meropenem, TE = Tetracycline, IMP = Imipenem, NOR = Norfloxacin, NA = Nalidixic acid, C = Chloramphenicol.
Figure 1. Species-wise representation of antibiotics resistance pattern of the Enterobacteriaceae isolates. CTX = Cefotaxime, S = Streptomycin, CIP = Ciprofloxacin, TOB = Tobramycin, CN = Gentamycin, CRO = Ceftriaxone, FOS = Fosfomycin, MEM = Meropenem, TE = Tetracycline, IMP = Imipenem, NOR = Norfloxacin, NA = Nalidixic acid, C = Chloramphenicol.
Antibiotics 12 01060 g001
Figure 2. Antibiotic resistance patterns of E. coli, Salmonella spp. and Klebsiella pneumoniae isolated from different sources. CTX = Cefotaxime, S = Streptomycin, CIP = Ciprofloxacin, TOB = Tobramycin, CN = Gentamycin, CRO = Ceftriaxone, FOS = Fosfomycin, MEM = Meropenem, TE = Tetracycline, IMP = Imipenem, NOR = Norfloxacin, NA = Nalidixic acid, C = Chloramphenicol, CS = Cloacal swab, L = Litter, M = Meat.
Figure 2. Antibiotic resistance patterns of E. coli, Salmonella spp. and Klebsiella pneumoniae isolated from different sources. CTX = Cefotaxime, S = Streptomycin, CIP = Ciprofloxacin, TOB = Tobramycin, CN = Gentamycin, CRO = Ceftriaxone, FOS = Fosfomycin, MEM = Meropenem, TE = Tetracycline, IMP = Imipenem, NOR = Norfloxacin, NA = Nalidixic acid, C = Chloramphenicol, CS = Cloacal swab, L = Litter, M = Meat.
Antibiotics 12 01060 g002
Figure 3. MDR patterns of colistin-resistant Enterobacteriaceae isolates.
Figure 3. MDR patterns of colistin-resistant Enterobacteriaceae isolates.
Antibiotics 12 01060 g003
Figure 4. Co-existence of antimicrobial resistant genes in colistin-resistant Enterobacteriaceae.
Figure 4. Co-existence of antimicrobial resistant genes in colistin-resistant Enterobacteriaceae.
Antibiotics 12 01060 g004
Figure 5. Species-wise co-existence of antimicrobial resistant genes in colistin-resistant Enterobacteriaceae.
Figure 5. Species-wise co-existence of antimicrobial resistant genes in colistin-resistant Enterobacteriaceae.
Antibiotics 12 01060 g005
Table 1. Multidrug resistance profile of mcr-harbouring Enterobacteriaceae isolates.
Table 1. Multidrug resistance profile of mcr-harbouring Enterobacteriaceae isolates.
IsolatesNo. of Antibiotics (Class)Multidrug ProfileNo. of Isolates (%)Prevalence of MDR%
mcr carriage Enterobacteriaceae
(n = 7)
1 (1)Any one of the tested antibiotics0100
2 (2)Combination of any two antibiotics0
5 (4)TOB, CN, TE, C, CL1 (14.28)
6 (5)TOB, CN, NA, CIP, NOR, CL1 (14.28)
7 (6)S, TE, NA, CIP, NOR, C, CL2 (28.57)
10 (6)TOB, CN, S, TE, NA, CIP, CTX, CRO, C, CL
9 (7)S, TE, NA, CIP, NOR, CTX, FOS, C, CL3 (42.86)
11 (7)TOB, CN, S, TE, NA, CIP, CTX, CRO, FOS, C, CL
11 (7)TOB, CN, S, TE, CIP, NOR, CTX, CRO, FOS, C, CL
Aminoglycosides (TOB = Tobramycin, CN = Gentamycin, S = Streptomycin), Fluoroquinolones (NA = Nalidixic acid, CIP = Ciprofloxacin, NOR = Norfloxacin), Tetracyclines (TE = Tetracycline), Cephalosporin (CTX = Cefotaxime, CRO = Ceftriaxone), Fosfomycins (FOS = Fosfomycin), Chloramphenicol (C), Polymyxins (CL = Colistin), MDR = Multidrug resistance.
Table 2. Prevalence of AMR genes in Enterobacteriaceae isolated from different sources.
Table 2. Prevalence of AMR genes in Enterobacteriaceae isolated from different sources.
SourcesAntibiotic Resistance Genes Profile (%)
blaTEMp-ValueblaSHVp-ValueblaCTX-Mp-ValuetetAp-ValuefloRp-ValuecatA1p-Valueaac-3-IVp-ValueaadA1p-ValuefosAp-Valueaac(6′)-Ibp-Value
Cloacal swab
(n = 12)
5 (41.7)0.8681 (8.3)0.030nc9 (75)0.0254 (33.3)0.0300.7754 (33.3)0.454 (33.3)0.0022 (16.7)0.1054 (33.3)0.067
Litter
(n = 6)
2 (33.3)2 (33.3)05 (83.3)5 (83.3)01 (16.7)4 (66.7)2 (33.3)2 (33.3)
Meat
(n = 36)
12 (33.3)1 (2.8)014 (38.9)10 (27.8)1 (2.8)11 (20.4)3 (8.3)2 (5.6)3 (8.3)
Total
(n = 54)
19 (35.2) 4 (7.4) 0 28 (51.9) 19 (35.2) 1 (1.9) 11 (20.4) 6 (11.1) 9 (16.7) 9 (16.7)
nc = not computed.
Table 3. Antimicrobial resistance gene (ARG) patterns in colistin-resistant Enterobacteriaceae (E. coli, n = 32; Salmonella spp., n = 16 and K. pneumoniae, n = 6).
Table 3. Antimicrobial resistance gene (ARG) patterns in colistin-resistant Enterobacteriaceae (E. coli, n = 32; Salmonella spp., n = 16 and K. pneumoniae, n = 6).
IsolatesStrainsARG PatternsNo. of ARGNo. of Isolates (%)
E. coliE297blaTEM, tetA, floR, aac-3-IV, aadA1, fosA, aac(6_)-lb71 (3.13)
E. coliE48blaTEM, tetA, floR, aac-3-IV, aadA1, aac(6_)-lb61 (3.13)
E. coliE172tetA, floR, aac-3-IV, aadA1, aac(6_)-lb51 (3.13)
E. coliE49blaTEM, tetA, floR, aadA1, aac(6_)-lb51 (3.13)
E. coliE278blaTEM, floR, catA1, aac-3-IV, aac(6_)-lb51 (3.13)
E. coliE275blaTEM, tetA, floR, aac-3-IV41 (3.13)
E. coliAntibiotics 12 01060 i001
E. coliblaTEM, tetA, floR, aadA144 (12.5)
E. coli
E. coliE446
E. coliE331blaTEM, tetA, floR, aac(6_)-lb41 (3.13)
E. coliAntibiotics 12 01060 i002blaTEM, tetA, aac-3-IV32 (6.25)
E. coli
E. coliAntibiotics 12 01060 i003blaTEM, tetA22 (6.25)
E. coli
E. coliAntibiotics 12 01060 i004tetA12 (6.25)
E. coli
E. coli--015 (46.87)
Salmonella spp.S283blaTEM, tetA, floR, aac-3-IV, fosA, aac(6_)-lb61 (6.25)
Salmonella spp.S242blaTEM, tetA, floR, aadA1, fosA51 (6.25)
Salmonella spp.Antibiotics 12 01060 i005
Salmonella spp.blaTEM, tetA, floR, aac-3-IV43 (18.75)
Salmonella spp.
Salmonella spp.Antibiotics 12 01060 i006
Salmonella spp.tetA13 (18.75)
Salmonella spp.
Salmonella spp.--08 (50)
K. pneumoniaeAntibiotics 12 01060 i007blaSHV, tetA, floR, aadA1, fosA, aac(6_)-lb62 (33.3)
K. pneumoniae
K. pneumoniaeK55blaSHV, tetA, floR31 (16.67)
K. pneumoniaeK402blaSHV, fosA21 (16.67)
K. pneumoniae--02 (33.3)
β-lactamase genes (blaTEM and blaSHV), Aminoglycosides (Gentamycin, aac-3-IV, Streptomycin, aadA1), Fluoroquinolones (Ciprofloxacin, aac(6_)-lb), Tetracyclines (Tetracycline, tetA), Chloramphenicol (catA1 and floR) and Fosfomycins (Fosfomycin, fosA).
Table 4. Antimicrobial resistance gene (ARG) patterns in mcr-habouring colistin-resistant Enterobacteriaceae (E. coli, n = 6, Salmonella spp., n = 1).
Table 4. Antimicrobial resistance gene (ARG) patterns in mcr-habouring colistin-resistant Enterobacteriaceae (E. coli, n = 6, Salmonella spp., n = 1).
SourcesStrainsCol-R GeneOther ARG PatternsNo. of ARGNo. of Isolates (%)
Cloacal swabE13mcr-1blaTEM, tetA, aac-3-IV31 (14.3)
E48mcr-1blaTEM, tetA, floR, aac-3-IV, aadA1, aac(6_)-lb61 (14.3)
E297mcr-1blaTEM, tetA, floR, aac-3-IV, aadA1, fosA, aac(6_)-lb71 (14.3)
LitterE172mcr-1tetA, floR, aac-3-IV, aadA1, aac(6_)-lb51 (14.3)
MeatE278mcr-1blaTEM, floR, catA1, aac-3-IV, aac(6_)-lb51 (14.3)
E331mcr-1blaTEM, tetA, floR, aac(6_)-lb41 (14.3)
S283mcr-5blaTEM, tetA, floR, aac-3-IV, fosA, aac(6_)-lb61 (14.3)
β-lactamase genes (blaTEM and blaSHV), Aminoglycoside resistance genes (Gentamycin, aac-3-IV; Streptomycin, aadA1), Fluoroquinolone resistance genes (Ciprofloxacin, aac(6-)-lb), Tetracycline resistance genes (Tetracycline, tetA), Chloramphenicol resistance genes (catA1 and floR) and Fosfomycin resistance genes (Fosfomycin, fosA), E = E. coli, S = Salmonella spp.
Table 5. List of colistin-resistant Enterobacteriaceae isolated from different samples of poultry and poultry meats.
Table 5. List of colistin-resistant Enterobacteriaceae isolated from different samples of poultry and poultry meats.
IsolatesSourcesNumber of Isolates
E. coli
(n = 32)
Meat23
CS7
Litter2
Salmonella spp.
(n = 16)
Meat11
CS3
Litter2
K. pneumoniae
(n = 6)
Meat2
CS2
Litter2
Total54
CS, cloacal swab.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karim, M.R.; Zakaria, Z.; Hassan, L.; Mohd Faiz, N.; Ahmad, N.I. Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes in mcr-Harbouring Colistin-Resistant Enterobacteriaceae Isolates Recovered from Poultry and Poultry Meats in Malaysia. Antibiotics 2023, 12, 1060. https://doi.org/10.3390/antibiotics12061060

AMA Style

Karim MR, Zakaria Z, Hassan L, Mohd Faiz N, Ahmad NI. Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes in mcr-Harbouring Colistin-Resistant Enterobacteriaceae Isolates Recovered from Poultry and Poultry Meats in Malaysia. Antibiotics. 2023; 12(6):1060. https://doi.org/10.3390/antibiotics12061060

Chicago/Turabian Style

Karim, Md. Rezaul, Zunita Zakaria, Latiffah Hassan, Nik Mohd Faiz, and Nur Indah Ahmad. 2023. "Antimicrobial Resistance Profiles and Co-Existence of Multiple Antimicrobial Resistance Genes in mcr-Harbouring Colistin-Resistant Enterobacteriaceae Isolates Recovered from Poultry and Poultry Meats in Malaysia" Antibiotics 12, no. 6: 1060. https://doi.org/10.3390/antibiotics12061060

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop